Over half of patients saw an improvement after being treated with biological therapies for inflammatory bowel disease (IBD). Data from the first national report of biological therapies shows that 62% of adult patients and 73% of paediatric patients saw the severity of their disease decrease after 12 weeks of treatment with biological therapy. IBD affects approximately 240,000 people in the UK[1] and patients with Ulcerative Colitis (UC) and Crohn's Disease (CD) will often require surgery during their lifetime...
More...
More...